Project: International Research Alliance for Antibiotic Discovery and Development

Acronym IRAADD (Reference Number: JPIAMR_2018_N025)
Duration 01/01/2019 - 31/03/2021
Project Topic The IRAADD network includes internationally renowned groups with excellent records of accomplishment in AMR research focussing on early stages of antibiotic discovery and development. This expert team will include natural products researchers, medical microbiologists, bioinformaticians, medicinal chemists and target-based drug designers, as well advisory partners from global alliances focussing on antibiotic development such as DNDi/GARDP and IMI-ENABLE. The partners of the network will set up a cooperative platform that will allow the sharing of scientific research data, translational knowledge and expert advice for the strategic development of new and advanced projects with the aim to take collaborative scientific research in the early stages of antibiotics discovery and development to a new level. IRAADD believes that such an integrative research network with international outreach will be an important step forward to close the gap in translational drug development, which has been lasting for several decades. IRAADD will represent a consortium of leaders from academia and other sectors who will actively address the worldwide concern of spreading AMR. While this crisis is steadily expanding, research and development of novel antibiotics is inhibited because of underfinanced discovery and development projects prior to the preclinical trial phase, which are essential to provide new and innovative antibiotics for saving patient lives today and in future. In addition, there is currently no network available to leverage the ideas and projects of academic groups, which typically do not move forward towards application. Thus, our initiative aligns with the current “One Health Action Plan against Antimicrobial Resistance” introduced by the European Commission, which explicitly demands the implementation and support of “research into the development of new antimicrobials” and the establishment of sustainable research networks in this area. However, IRAADD strongly believes that the current situation and available institutions do not efficiently allow for a coordination and coaching especially of academic partners regarding translation of urgently required research on novel antibiotics into clinical use.
Website visit project website
Network JPI AMR
Call 8th Joint Call of JPIAMR

Project partner

Number Name Role Country
1 Helmholtz Centre for Infection Research Coordinator Germany
2 Shandong University Observer China
3 Technical University of Denmark Observer Denmark
4 Pasteur Institute Observer France
5 Université de Lorraine Observer France
6 University of Lorraine Observer France
7 Université Paris-Saclay Observer France
8 French National Museum of Natural History Observer France
9 Pasteur Institute Observer France
10 University of Strasbourg Observer France
11 University of Tübingen Observer Germany
12 University of Frankfurt Observer Germany
13 Bielefeld University Observer Germany
14 Helmholtz Centre for Infection Research Observer Germany
15 Bonn University Medical Center Observer Germany
16 Saarland University Observer Germany
17 University of Bonn Observer Germany
18 University of Tübingen Observer Germany
19 University of Perugia Observer Italy
20 NAICONS Srl Observer Italy
22 University of Parma Observer Italy
23 Leiden University Observer Netherlands
24 AMR Insights Observer Netherlands
25 Wageningen University & Research Observer Netherlands
26 Polish Academy of Sciences Observer Poland
27 University of Lisbon Observer Portugal
28 University of Ljubljana Observer Slovenia
29 University of Cape Town Observer South Africa
30 Fundación MEDINA Observer Spain
31 Uppsala University Observer Sweden
32 ETH Zurich Observer Switzerland
33 University of Bern Observer Switzerland
34 University of Manchester Observer United Kingdom
35 John Innes Centre Observer United Kingdom
36 University of Dundee Observer United Kingdom
37 University Hospital Tübingen Observer Germany